Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: airtight package for oversea shipment
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000KGS monthly
Port: BEIJING,SHANGHAI,QINGDAO
Payment Type: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
It is a histamine H1-receptor antagonist and mast cell stabilizer. It inhibits the release of histamine from mast cells and prevents the effect of histamine, thereby reducing allergic reactions. In addition, it has the effect of reducing chemotaxis and inhibiting the activity of eosinophils. Vistakon Pharmaceuticals successfully listed Lastacaft, which is another drug used to treat allergic conjunctivitis-related itching after Bepreve developed by ISTA Pharmaceuticals. They are bound to be the cause of eye diseases. Patients bring huge benefits, and its application prospects are very broad.
product | 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]iMidazo[1,2-a]azepine |
CAS | 147083-36-1 |
MF | C18H21N3 |
MW | 279.38 |
Product Categories : API Intermediates > Alcaftadine Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.